Not meant for U.S. and UK Media
Berlin, January 23, 2023 — Bayer revealed today that its iodine-based contrast representative Ultravist ™ -300, -370 is now authorized for contrast-enhanced mammography (CEM) in the EU. The item can be utilized to examine and discover sores of the breast as an accessory to mammography (with or without ultrasound) or as an option when a magnetic resonance imaging (MRI) is contraindicated or not available. Following the approval of the European Workshare Procedure (a decentralized shared acknowledgment procedure on EU level), the very first nationwide approvals in the EU are anticipated in the very first quarter of 2023. CEM is an emerging technique that integrates digital mammography with the administration of a contrast representative, such as Ultravist, to support the medical diagnosis of breast cancer and guide treatment choices. The approval broadens Bayer’s radiology portfolio, that includes contrast media, injectors in addition to digital and expert system (AI) made it possible for services, supporting radiologists throughout a broad variety of illness consisting of breast cancer.
“Breast cancer is the most typical cancer worldwide, affecting countless females and their liked ones all over the world,” stated Dr. Julia Camps Herrero, Corporate Chief of Breast Health, Ribera Salud Hospitals Spain. “Early detection of cancer can conserve lives. Imaging choices such as contrast-enhanced mammography can assist enhance diagnostic precision, possibly recognizing cancers that otherwise may have been missed out on.”
“The approval of Ultravist-300 and -370 in contrast-enhanced mammography offers doctors a brand-new imaging alternative where standard mammography may not suffice,” stated Dr. Konstanze Diefenbach, Head of Radiology Research and Development, Bayer. “We are delighted to be able to use extra choices for breast imaging to health care experts, as we intend to support them in their function of offering clear instructions from medical diagnosis to look after clients.”
About breast cancer and contrast-enhanced mammography
In 2020, there were 2.3 million females identified with breast cancer and 685 000 deaths internationally, according to the World Health Organization (WHO). Breast cancer treatment can be really efficient, particularly when the illness is recognized early. CEM is an extremely delicate